Anebulo Pharmaceuticals Inc ANEB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 06/11/21 EDT
8.03quote price arrow down-0.01 (-0.12%)
Volume
11,933
52 week range
6.31 - 9.33

...

Loading . . .
  • Open7.88
  • Day High8.25
  • Day Low7.51
  • Prev Close8.04
  • 52 Week High9.33
  • 52 Week High Date05/21/21
  • 52 Week Low6.31
  • 52 Week Low Date05/14/21

Key Stats

  • Market Cap186.86M
  • Shares Out23.27M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open7.88
  • Day High8.25
  • Day Low7.51
  • Prev Close8.04
  • 52 Week High9.33
  • 52 Week High Date05/21/21
  • 52 Week Low6.31
  • 52 Week Low Date05/14/21
  • Market Cap186.86M
  • Shares Out23.27M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-1,070.67
  • Fwd P/E (NTM)-44.61
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)9.28%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Anebulo Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing solutions for people suffering from cannabinoid overdose and substance addiction. The Company's lead product candidate, ANEB-001, is a potent, small molecule cannabinoid receptor antagonist, designed to address the unmet medical need for a specific antidote for cannabinoid overdose. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety...
Address
1415 Ranch Road 629 South, Suite 201
Lakeway, TX
78734
United States